Cancer Treatment: National Cancer Institute's Role in Encouraging the Use of Breakthroughs
PEMD-89-4BR
Published: Oct 20, 1988. Publicly Released: Nov 21, 1988.
Skip to Highlights
Highlights
In response to a congressional request, GAO examined the role that the National Cancer Institute (NCI) plays in promoting physicians' utilization of breakthroughs in cancer therapies.
Recommendations
Matter for Congressional Consideration
| Matter | Status | Comments |
|---|---|---|
| Congressional committees that are concerned about efforts to promote the adoption of cancer treatment advances may want to consider steps to specifically mandate federal action. This could include directing NCI, or some other office created for this purpose, to undertake efforts to clearly identify and promote the use of cancer therapies that have been sufficiently proven to warrant being classified as recommended treatments. |
Closed – Not Implemented
|
No congressional action is anticipated. |
Full Report
Office of Public Affairs
Topics
CancerCancer researchHealth services administrationMedical information systemsPatient care servicesPhysiciansTherapyChemotherapyColon cancerPublications